Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3546]

MicroRNA as a treatment for chronic myelogenous leukaemia

Prof Danilo Perrotti - The Ohio State University, USA

MicroRNA as a treatment for chronic myelogenous leukaemia ( Prof Danilo Perrotti - The Ohio State University, USA )

Developments in the treatment of acute myeloid leukaemia (AML)

Professor Alan Burnett - Cardiff University, UK

Developments in the treatment of acute myeloid leukaemia (AML) ( Professor Alan Burnett - Cardiff University, UK )

Phase III clinical trials at ASCO 2010

Prof Patrick Schöffski - Catholic University Leuven, Belgium

Phase III clinical trials at ASCO 2010 ( Prof Patrick Schöffski - Catholic University Leuven, Belgium )

Drug developments presented at ASCO 2010

Dr Silvia Marsoni - Mario Negri Institute, Milan, Italy and Prof Filippo de Braud - European Institute of Oncology, Milan, Italy

Drug developments presented at ASCO 2010 ( Dr Silvia Marsoni - Mario Negri Institute, Milan, Italy and Prof Filippo de Braud - European Institute of Oncology, Milan, Italy )

Advances in the treatment of melanoma

Prof Alexander Eggermont - Erasmus University of Rotterdam, Netherlands

Advances in the treatment of melanoma ( Prof Alexander Eggermont - Erasmus University of Rotterdam, Netherlands )

Advances in melanoma treatment

Prof John Wagstaff - University of Swansea, Wales

Advances in melanoma treatment ( Prof John Wagstaff - University of Swansea, Wales )

PARP inhibitors

Professor Hilary Calvert - University College London, UK

PARP inhibitors ( Professor Hilary Calvert - University College London, UK )

Biotherapy Development Association

Prof Heinz Zwierzina - Innsbruck Medical University, Austria

Biotherapy Development Association ( Prof Heinz Zwierzina - Innsbruck Medical University, Austria )

The PRIMA study

Prof Gilles Salles - Universite Claude Bernard Lyon, France

The PRIMA study ( Prof Gilles Salles - Universite Claude Bernard Lyon, France )

ALK mutation related non-small cell lung cancer

Prof George Demetri - Harvard Medical School, USA

ALK mutation related non-small cell lung cancer ( Prof George Demetri - Harvard Medical School, USA )

A new centre of excellence for lung cancer treatment

Dr Thierry Le Chevalier - Gustave-Roussy Institute, Villejuif, France

A new centre of excellence for lung cancer treatment ( Dr Thierry Le Chevalier - Gustave-Roussy Institute, Villejuif, France )

Clinical trial Design: Comparator arms

Prof David Cameron, Dr Christopher M Nutting, Dr Ruth Pettengell, Professor Jacek Jassem

Clinical trial Design: Comparator arms ( Prof David Cameron, Dr Christopher M Nutting, Dr Ruth Pettengell, Professor Jacek Jassem )

More from ecancer